Skip to main content
. Author manuscript; available in PMC: 2016 Apr 21.
Published in final edited form as: J Med Chem. 2016 Jan 29;59(3):1102–1115. doi: 10.1021/acs.jmedchem.5b01696

Table 1.

Compounds at 1 µM that Decrease 7-DHC in Dhcr7-Deficient Neuro2a Cellsg

graphic file with name nihms756311t1.jpg
g

All compounds assayed at 1 µM in 384 well plate. Compounds affect steps promoted by HMG (HMGCoA reductase), Δ8–7, (Δ8–7 isomerase), DR24 (DHCR24 reductase) or CYP51 (CYP).

a

Activity confirmed in human fibroblasts (control or SLOS).

b

Compound not in NIH Clinical Collection.

c

See ref 59.

d

Lanosterol increase in both deficient Neuro2a and fibroblasts.

e

Decrease of all sterol intermediates.

f

See ref 60.